Novartis Investigative Site

Sequim, Washington 98382

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Non-Hodgkin's Lymphoma

Studies at this site

• Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer — Completed
• Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy — Stopped early